Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             146 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A Comparison of the Phenotypic Susceptibility Profiles of Emtricitabine and Lamivudine Borroto-Esoda, Katyna
2007
5 p. 297-300
artikel
2 Activity of a Sulfated Polysaccharide Extracted from the Red Seaweed Aghardhiella Tenera against Human Immunodeficiency Virus and Other Enveloped Viruses Witvrouw, M.
1994
5 p. 297-303
artikel
3 Acute and Delayed Toxicity Studies on the Antiherpesvirus Agents 5-Methoxymethyl-2′-Deoxycytidine and 5-Methoxymethyl-2′-Deoxyuridine Shi, R
1997
5 p. 439-442
artikel
4 Acute Infection of Cynomolgus Monkeys with Simian Immunodeficiency Virus (SIVSM) as a Model to Evaluate Antiviral Compounds. Effects of 3′-Azido, 3′-Deoxythymidine, Foscarnet and 2′,3′-Dideoxycytidine Lundgren, B.
1990
5 p. 299-306
artikel
5 Acyclovir Treatment of Skin Lesions Results in Immune Deviation in Mice Infected Cutaneously with Herpes Simplex Virus Li, ZhiHong
1999
5 p. 251-257
artikel
6 A Diarylsulphone Non-Nucleoside Reverse Transcriptase Inhibitor with a Unique Sensitivity Profile to Drug-Resistant Virus Isolates Buckheit, R.W.
1996
5 p. 243-252
artikel
7 5-Alkynyl Pyrimidine Nucleosides as Potent Selective Inhibitors of Varicella-Zoster Virus Rahim, S. G.
1992
5 p. 293-297
artikel
8 Amino- and Hydroxytetraphenylporphyrins with Activity against the Human Immunodeficiency Virus Dixon, D. W.
1992
5 p. 279-282
artikel
9 An Appraisal of the Efficacy of the Antiviral R 61837 in Rhinovirus Infections in Human Volunteers Barrow, G. I.
1990
5 p. 279-283
artikel
10 An Approach towards the Synthesis of Potential Metal-Chelating TSAO-T Derivatives as Bidentate Inhibitors of Human Immunodeficiency virus Type 1 Reverse Transcriptase Chamorro, C
1998
5 p. 412-421
artikel
11 A Novel Substance Purified from Perilla Frutescens Britton Inhibits an Early Stage of HIV-1 Replication without Blocking Viral Adsorption Kawahata, T
2002
5 p. 283-288
artikel
12 Anti-Bovine Viral Diarrhoea Virus Activity of Novel Diphenylmethane Derivatives Salim, Mohammed TA
2010
5 p. 193-200
artikel
13 Antiherpes Virus Activities of New 6–19 Carbon-Bridged Steroids and Some Synthetic Precursors Petrera, Erina
2003
5 p. 243-248
artikel
14 Antiherpesvirus Activity of the Combination of 5-iodo-2′-deoxycytidine with methotrexate: An in vitro and in vivo Study Cremonesi, C.
1994
5 p. 283-289
artikel
15 Anti-HIV-1 Activity and Structure-Activity Relationship of Cepharanoline Derivatives in Chronically Infected Cells Baba, M
2001
5 p. 307-312
artikel
16 Anti-HIV-1 Activity of Calanolides Used in Combination with other Mechanistically Diverse Inhibitors of HIV-1 Replication Buckheit, Robert W
2000
5 p. 321-327
artikel
17 Anti-HIV Activity of MDL 74968, a Novel Acyclonucleotide Derivative of Guanine: Drug Resistance and Drug Combination Effects in Vitro Taylor, D.L.
1996
5 p. 253-260
artikel
18 Anti-Human Immunodeficiency Virus Type 1 Activity of R-95288, a Phosphodiester Hexadeoxyribonucleotide Modified by Dibenzyloxybenzyl and Hydroxyethyl Residues at the 5′- and 3′-Ends Agatsuma, T
1997
5 p. 429-438
artikel
19 Anti-Influenza Virus Activities of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N-(4,6-dimethyl-2-pyrimidin-2-yl)benzenesulphonamide and its Derivatives Selvam, Periyasamy
2006
5 p. 269-274
artikel
20 Antipicornavirus Drugs: Current Status Diana, GD
1997
5 p. 401-408
artikel
21 Antipoliovirus Flavonoids from Psiadia Dentata Robin, Valérie
2001
5 p. 283-291
artikel
22 Anti-Varicella—Zoster Virus Bicyclic Nucleosides: Replacement of Furo by Pyrro Base Reduces Antiviral Potency McGuigan, C
2000
5 p. 343-348
artikel
23 Antiviral Activity of Cyclosaligenyl Prodrugs of Acyclovir, Carbovir and Abacavir Balzarini, Jan
2001
5 p. 301-306
artikel
24 Antiviral Activity of Nucleoside Analogues against SARS-coronavirus (SARS-CoV) Chu, Chung K
2006
5 p. 285-289
artikel
25 Antiviral and Cytostatic Evaluation of the Novel 6-acyclic Chain Substituted Thymine Derivatives Prekupec, Svjetlana
2005
5 p. 327-338
artikel
26 Antiviral Effect of Interferon Therapy for Patients with Chronic Hepatitis C Hayashi, J.
1992
5 p. 305-309
artikel
27 Antiviral Pharmacodynamics in Hollow Fibre Bioreactors McSharry, James J
2011
5 p. 183-192
artikel
28 Antiviral Research at the Rega Institute (KU Leuven), Now 50 Years Old De Clercq, Erik
2004
5 p. 223-233
artikel
29 A Survey of Antiviral Drugs for Bioweapons Goff, Arthur J.
2005
5 p. 283-294
artikel
30 Basis of Relative Insensitivity of HIV-Infected JM Cells to AZT Snyder, R. D.
1995
5 p. 307-311
artikel
31 Bicyclic Nucleoside Inhibitors of Varicella-Zoster Virus: Effect of Terminal Aryl Substitution in the Side-Chain Carangio, A
2002
5 p. 263-271
artikel
32 Biochemical Pharmacology of 2′-Fluoro-2′,3′-Dideoxyarabinosyladenine, an Inhibitor of HIV with Improved Metabolic and Chemical Stability over 2′,3′-Dideoxyadenosine Hitchcock, M. J. M.
1990
5 p. 319-327
artikel
33 Book Review: Microbial Subversion of Immunity: Current Topics Field, Hugh J
2006
5 p. 291-291
artikel
34 Brain Targeting of anti-HIV Nucleosides: Ether Prodrugs of 3′-Azido-2′,3′-Dideoxyuridine (AZdU) and 3′-Azido-3′-Deoxythymidine (AZT) Doshi, K. J.
1993
5 p. 263-269
artikel
35 Brain Targeting of anti-HIV Nucleosides: in vitro and in vivo Evaluation of 6-chloro-2′,3′-dideoxypurine, a Lipophilic Prodrug of 2′,3′-dideoxyinosine Doshi, K. J.
1994
5 p. 304-311
artikel
36 Broad-Spectrum Antiviral Activity and Mechanism of Antiviral Action of the Fluoroquinolone Derivative K-12 Witvrouw, M
1998
5 p. 403-411
artikel
37 CCR5 Antagonists: Host-Targeted Antiviral Agents for the Treatment of HIV Infection, 4 Years on Westby, Mike
2010
5 p. 179-192
artikel
38 Cellular Metabolism and Anti-Influenza Activity of 1,3,4-Thiadiazol-2-Ylcyanamide (LY217896) Colacino, J. M.
1993
5 p. 271-280
artikel
39 Changes of HBV Markers in Serum and Liver Tissue in Patients with Chronic Hepatitis B Treated with Recombinant Alpha-Interferon (rIFN-α): Results of a Controlled Study Pastore, G.
1990
5 p. 329-331
artikel
40 Characterization of HIV Reverse Transcriptases with Tyr181→Cys and Leu100→lle Mutations Zhang, H.
1993
5 p. 301-308
artikel
41 Chemistry and Anti-Herpes Simplex virus Type 1 Evaluation of CycloSal-Nucleotides of Acyclic Nucleoside Analogues Meier, C
1998
5 p. 389-402
artikel
42 Conformational Analysis of Substituent Effects on the Sugar Puckering Mode and the anti-HIV Activity of 2′,3′-Dideoxypyrimidine Nucleosides Everaert, D. H.
1993
5 p. 289-299
artikel
43 Differences in DNA Packaging Genes and Sensitivity to Benzimidazole Ribonucleosides between Human Cytomegalovirus Strains AD169 and Towne Krosky, Paula M
2000
5 p. 349-352
artikel
44 Differential Susceptibility of Several Drug-Resistant Strains of Herpes Simplex Virus Type 2 to Various Antiviral Compounds Andrei, G
1997
5 p. 457-461
artikel
45 Dimeric Macrocyclic Polyamines with Potent Inhibitory Activity against Human Immunodeficiency Virus Inouye, Y.
1995
5 p. 337-344
artikel
46 3-(5-Dimethylamino-1-Naphthalenesulphonyl)-2-(3-Pyridyl)Thiazolidine (YHI-1) Selectively Inhibits Human Immunodeficiency virus Type 1 Premanathan, M
1998
5 p. 423-430
artikel
47 Dipyridamole Potentiates the Activity of Various Acyclic Nucleoside Phosphonates against Varicella-Zoster Virus, Herpes Simplex Virus and Human Cytomegalovirus Snoeck, R.
1994
5 p. 312-321
artikel
48 Effect of Daily Zidovudine (AZT) Pulse-Therapy on Replication of Human Immunodeficiency Virus Type 1 and Type 2 in vitro Vogt, M. W.
1990
5 p. 293-298
artikel
49 Enhancement of the Antiviral Activity of Poly (A-U) by Adriamycin and Daunomycin Jamison, J. M.
1990
5 p. 285-292
artikel
50 1-(Ethoxymethyl)-6-(Phenylselenenyl)Pyrimidines with Activity against Human Immunodeficiency Virus Types 1 and 2 Goudgaon, N. M.
1992
5 p. 263-266
artikel
51 Evaluation of Immunomodulators, Interferons and Known in Vitro SARS-CoV Inhibitors for Inhibition of SARS-Cov Replication in BALB/c Mice Barnard, Dale L
2006
5 p. 275-284
artikel
52 α-Glucosidase Inhibitors Have a Prolonged Antiviral Effect against Hepatitis B Virus through the Sustained Inhibition of the Large and Middle Envelope Glycoproteins Simsek, Ender
2006
5 p. 259-267
artikel
53 Herpes Simplex Virus Isolates from an Immunocompromised Patient who Failed to Respond to Acyclovir Treatment Express Thymidine Kinase with Altered Substrate Specificity Nugier, F.
1991
5 p. 295-302
artikel
54 HIV Immunotherapeutic Vaccines Peters, Barry S
2000
5 p. 311-320
artikel
55 HIV Type-1 Latency: Targeted Induction of Proviral Reservoirs Graci, Jason D
2009
5 p. 177-187
artikel
56 Human Cytomegalovirus: Challenges Opportunities and New Drug Development Field, A Kirk
1999
5 p. 219-232
artikel
57 Imino Sugars That are Less Toxic but More Potent as Antivirals, In Vitro, Compared with N-n-Nonyl DNJ Mehta, Anand
2002
5 p. 299-304
artikel
58 Improved Delivery through Biological Membranes. Synthesis, Characterization and Antiviral Activity of a Series of Ribavirin Chemical Delivery Systems: 5 and Carboxamide Derivatives Bhagrath, M.
1991
5 p. 265-286
artikel
59 Influence of the Infectious Dose of Simian Immunodeficiency Virus on the Acute Infection in Cynomolgus Monkeys and on the Effect of Treatment with 3′-Fluorothymidine Böttiger, D.
1992
5 p. 267-271
artikel
60 Ingenol Derivatives are Highly Potent and Selective Inhibitors of HIV Replication in Vitro Fujiwara, M.
1996
5 p. 230-236
artikel
61 Inhibition of Hepatitis B Virus Replication by Nucleoside Enantiomers of β-2′,3′-Dideoxypurine Analogues Alaoui, A.M. El
1996
5 p. 276-280
artikel
62 Inhibition of HIV-1 and LP-BM5 Replication in Macrophages by Dideoxycytidine and Dideoxycytidine 5′-Triphosphate Magnani, M.
1995
5 p. 312-319
artikel
63 Inhibition of HIV-1 Replication by an HIV-1 Dependent Ribozyme Expression Vector with the Cre/loxP (ON/OFF) System Habu, Yuichiro
2002
5 p. 273-281
artikel
64 Inhibition of Influenza A and B Viruses by 2′-Deoxy-2′-Fluororibosides Tisdale, M.
1993
5 p. 281-287
artikel
65 Inhibition of Influenza a Virus Replication by Antagonism of a PI3K-AKT-mTOR Pathway Member Identified by Gene-Trap Insertional Mutagenesis Murray, James L
2012
5 p. 205-215
artikel
66 Inhibition of Moloney Murine Leukaemia Virus Transcription by a Phospholipase-C Inhibitor Affecting Trans-Acting Factors Music, L.
1992
5 p. 283-291
artikel
67 Inhibition of Respiratory Syncytial Virus Replication in vitro by a Pyrazole Dicarboxamide Analogue of Ribavirin Woods, J. M.
1994
5 p. 340-343
artikel
68 Inosine Monophosphate Dehydrogenase as a Probe in Antiviral Drug Discovery Nair, Vasu
2007
5 p. 245-258
artikel
69 In vitro Activity of a Novel Series of Polyoxosilicotungstates against Human Myxo-, Herpes- and Retroviruses Ikeda, S.
1993
5 p. 253-262
artikel
70 In Vitro Activity of SPD754, a New Deoxycytidine Nucleoside Reverse Transcriptase Inhibitor (NRTI), against 215 HIV-1 Isolates Resistant to Other NRTIs Bethell, Richard C.
2005
5 p. 295-302
artikel
71 In vitro and Animal Models for Antiviral Therapy in Papillomavirus Infections Stanley, MA
1997
5 p. 381-400
artikel
72 In Vitro and in Vivo Activities of T-705 and Oseltamivir against Influenza Virus Takahashi, Kazumi
2003
5 p. 235-241
artikel
73 In vitro Evaluation of the Anti-Picornavirus Activities of New Synthetic Flavonoids Desideri, N.
1995
5 p. 298-306
artikel
74 In vitro Sequential Selection and Characterization of Human Immunodeficiency Virus Type 1 Variants with Reduced Sensitivity to Hydroxyethylurea Protease Inhibitors Potts, KE
1997
5 p. 447-456
artikel
75 In vitro Toxicity of 2′,3′-Dideoxy-3′-Thiacytidine (BCH189/3TC), a New Synthetic Anti-HIV-1 Nucleoside Lisignoli, G.
1992
5 p. 299-303
artikel
76 Isolation and Characterization of HIV-1 Isolates Resistant to Oxathiin Carboxanilide Analogues: Evaluation of Variables in the Drug Resistance Selection Process Kinjerski, T.L.
1996
5 p. 261-269
artikel
77 Isoquinolinesulphonamide Derivatives Inhibit Transcriptional Elongation of Human Immunodeficiency Virus Type 1 RNA in a Promyelocytic Model of Latency Critchfield, JW
1999
5 p. 275-284
artikel
78 Isothiazole Derivatives as Antiviral Agents Garozzo, Adriana
2007
5 p. 277-283
artikel
79 Lack of Efficacy of Aurintricarboxylic Acid and Ethacrynic Acid against Vaccinia Virus Respiratory Infections in Mice Smee, Donald F
2010
5 p. 201-205
artikel
80 Lymphatic Targeting of Anti-Human Immunodeficiency Virus Nucleosides: Pharmacokinetics of G′-Deoxy-2′,3′-Didehydrothymidine after Intravenous and Oral Administration of Dipalmitoylphosphatidyl Prodrug to Mice Manouilov, KK
1997
5 p. 409-415
artikel
81 Maporal Virus as a Surrogate for Pathogenic New World Hantaviruses and its Inhibition by Favipiravir Buys, Kristin K
2011
5 p. 193-200
artikel
82 Mechanisms of Action of Ribavirin in Antiviral Therapies Tam, Robert C
2001
5 p. 261-272
artikel
83 Medicinal Chemistry of Nucleoside Phosphonate Prodrugs for Antiviral Therapy Pertusat, Fabrizio
2012
5 p. 181-203
artikel
84 [Melle4]Cyclosporin, a Novel Natural Cyclosporin with anti-HIV Activity: Structural Elucidation, Biosynthesis and Biological Properties Traber, R.
1994
5 p. 331-339
artikel
85 Mesoionic Heterocyclic Compounds as Candidate Messenger RNA Cap Analogue Inhibitors of the Influenza Virus RNA Polymerase Cap-Binding Activity Mickleburgh, Ian
2009
5 p. 213-218
artikel
86 Molecular Targets for Human Papillomaviruses: Prospects for Antiviral Therapy Phelps, WC
1998
5 p. 359-377
artikel
87 Naturally Occurring Pyrrolizidines: Inhibition of α-Glucosidase 1 and Anti-HIV Activity of One Stereoisomer Taylor, D. L.
1992
5 p. 273-277
artikel
88 Novel 6-Azapyrimidine-2′-Deoxy-4′-Thionucleosides: Synthesis, Biological Evaluation and Conformational Analysis Inguaggiato, G
1999
5 p. 241-249
artikel
89 Novel Compounds for the Treatment of HIV Type-1 Infection Stellbrink, Hans-Jüurgen
2009
5 p. 189-200
artikel
90 Novel Phorbol Esters Exert Dichotomous Effects on Inhibition of HIV-1 Infection and Activation of Latent HIV-1 Expression Zhong, Yu
2005
5 p. 303-313
artikel
91 Novel 3-sulphonamido-quinazolin-4(3H)-One Derivatives: Microwave-Assisted Synthesis and Evaluation of Antiviral Activities against Respiratory and Biodefense Viruses Selvam, Periyasamy
2007
5 p. 301-305
artikel
92 Nucleoside Reverse Transcriptase Inhibitor Usage and the Incidence of Peripheral Neuropathy in HIV/AIDS Patients Dragovic, Gordana
2003
5 p. 281-284
artikel
93 Penciclovir-Resistance Mutations in the Herpes Simplex Virus DNA Polymerase Gene Chiou, Henry C.
1995
5 p. 281-288
artikel
94 Peptide Inhibitors of Hepatitis C Virus NS3 Protease Portal-Núñez, Sergio
2003
5 p. 225-233
artikel
95 Peptidyl Diazomethyl Ketones Inhibit the Human Rhinovirus 3C Protease: Effect on Virus Yield by Partial Block of P3 Polyprotein Processing Murray, Michael A
2001
5 p. 273-281
artikel
96 Pharmacokinetic Evaluation of 3′-Azido-2′, 3′-Dideoxyuridine-5′-O-Valinate-Hydrochloride as a Prodrug of the Anti-HIV Nucleoside 3′-Azido-2′, 3′-Dideoxyuridine Kong, Linghui
2003
5 p. 263-270
artikel
97 Phenotypic Resistance of Herpes Simplex Virus Type 1 Strains Selected in Vitro with Antiviral Compounds and Combinations Thereof Morfin, F.
1996
5 p. 270-275
artikel
98 Phosphoramidate Prodrugs of (−)-β-D-(2R,4R)-dioxolane-thymine (DOT) as Potent Anti-HIV Agents Wang, Peiyuan
2012
5 p. 217-238
artikel
99 Piperidinylethyl, Phenoxyethyl and Fluoroethyl Bromopyridyl Thiourea Compounds with Potent Anti-HIV Activity Venkatachalam, TK
2000
5 p. 329-336
artikel
100 Potent and Orally Bioavailable HIV-1 Proteinase Inhibitors Containing the 2-aminobenzylstatine Moiety Billich, A.
1995
5 p. 327-336
artikel
101 Potent β-Lactam Inhibitors of Human Cytomegalovirus Protease Yoakim, C
1998
5 p. 379-387
artikel
102 Profound Anti-HIV-1 Activity of DAPTA in Monocytes/macrophages and Inhibition of CCR5-mediated Apoptosis in Neuronal Cells Pollicita, Michela
2007
5 p. 285-295
artikel
103 Prospects for Antiviral Chemotherapy in Veterinary Medicine: 1. Feline Virus Diseases Rollinson, E. A.
1992
5 p. 249-262
artikel
104 Rapid Prescreening for Antiviral Agents against HIV-1 Based on Their Inhibitory Activity in Site-Directed Immunoassays. I. The V3 Loop of gp 120 as Target Neurath, A. R.
1991
5 p. 303-312
artikel
105 Recent Advances in the Synthesis of the Carbocyclic Nucleosides as Potential Antiviral Agents Jeong, Lak Shin
2004
5 p. 235-250
artikel
106 Recent Clinical Experience with Famciclovir — A ‘Third Generation’ Nucleoside Prodrug Chakrabarty, Arun
2004
5 p. 251-253
artikel
107 Retinazone Inhibits Certain Blood-Borne Human Viruses Including Ebola Virus Zaire Kesel, Andreas J
2014
5 p. 197-215
artikel
108 Rimantadine and Oseltamivir Demonstrate Synergistic Combination Effect in an Experimental Infection with Type a (H3N2) Influenza Virus in Mice Galabov, Angel S
2006
5 p. 251-258
artikel
109 San Francisco Welcomes 23rd ICAR 2010
5 p. 207-211
artikel
110 Sapporo, Japan welcomes 25th ICAR 2012
5 p. 239-247
artikel
111 Screening of Compounds for Activity against HIV: A Collaborative Study Holmes, H. C.
1991
5 p. 287-293
artikel
112 Selection of a Thiazole Urea-Resistant Variant of Bovine Viral Diarrhoea Virus That Maps to the RNA-Dependent RNA Polymerase King, Robert W
2002
5 p. 315-323
artikel
113 Short-Term Treatment with Novel Ribonucleotide Reductase Inhibitors Trimidox and Didox Reverses Late-Stage Murine Retrovirus-Induced Lymphoproliferative Disease with Less Bone Marrow Toxicity Than Hydroxyurea Mayhew, CN
2002
5 p. 305-314
artikel
114 Silencing of HIV-1 Gene Expression by Two Types of siRNA Expression Systems Hayafune, Masaaki
2006
5 p. 241-249
artikel
115 Small Molecule Inhibitors of West Nile Virus Elseginy, Samia A
2014
5 p. 179-187
artikel
116 Small Molecule Pan-Dengue and West Nile Virus NS3 Protease Inhibitors Cregar-Hernandez, Lynne
2011
5 p. 209-217
artikel
117 Spectrum of Virus Inhibition by Consensus Interferon YM643 Yasuda, Shuhei
2000
5 p. 337-341
artikel
118 Structure-Activity Relationship Studies on a Novel Family of Specific HIV-1 Reverse Transcriptase Inhibitors Bonache, María-Cruz
2003
5 p. 249-262
artikel
119 Structure-Based Design of Non-Nucleoside Reverse Transcriptase Inhibitors of Drug-Resistant Human Immunodeficiency Virus Mao, Chen
1999
5 p. 233-240
artikel
120 Synergistic Inhibition of HIV-1 Reverse Transcriptase and HIV-1 Replication by Combining Trovirdine with AZT, ddl and ddC in Vitro Zhang, H.
1996
5 p. 221-229
artikel
121 Syntheses and Biological Evaluation of 5′-O-Myristoyl Derivatives of Thymidine against Human Immunodeficiency Virus Parang, K
1997
5 p. 417-427
artikel
122 Synthesis and Anti-Herpes Activity of a Series of Indolizines Foster, C.
1995
5 p. 289-297
artikel
123 Synthesis and Anti-HIV Activity of Carbamates of Antiviral Agent Stavudine Venkatachalam, TK
2002
5 p. 289-297
artikel
124 Synthesis and Anti-Rhinovirus 1B Activity of Oxazolinylflavans Desideri, N.
1990
5 p. 307-312
artikel
125 Synthesis and Antiviral Activity of 1,3-Disubstituted Uracils against HIV-1 and HCMV Maruyama, Tokumi
2003
5 p. 271-279
artikel
126 Synthesis and Antiviral Evaluation of 4'-alkoxy Analogues of 9-(β-D-xylofuranosyl)adenine Kubota, Yutaka
2009
5 p. 201-212
artikel
127 Synthesis and Antiviral Evaluation of Phosphoramidate Derivatives of (E)-5-(2-Bromovinyl)-2′-Deoxyuridine Harris, SA
2001
5 p. 293-300
artikel
128 Synthesis and Biological Activity of 1H-benzotriazole and 1H-benzimidazole Analogues — Inhibitors of the NTPase/Helicase of HCV and of Some Related Flaviviridae Bretner, Maria
2005
5 p. 315-326
artikel
129 Synthesis and in vitro Antiviral Properties of Amphiphilic Dinucleoside Phosphate Derivatives of 2′,3-dideoxycytidine (ddC) Schott, H.
1995
5 p. 320-326
artikel
130 Synthesis, anti-HIV and anti-Proliferative Activity of New Urea and Nitrosourea Derivatives of Amino Acids Gallant, G.
1991
5 p. 313-319
artikel
131 Synthesis, Physicochemical and Pharmacokinetic Studies of Potential Prodrugs of β-L-2′-Deoxycytidine, a Selective and Specific Anti-HBV Agent Pierra, Claire
2004
5 p. 269-279
artikel
132 Synthesis, Structure and in Vitro Anti-Human Immunodeficiency virus Activity of Novel 3-Methyl-1H,3H-Thiazolo[3,4-a]Benzimidazoles Chimirri, A
1998
5 p. 431-438
artikel
133 The Activity of Ribavirin against the Human Immunodeficiency Virus: A Review of Laboratory and Clinical Experience Snell, N. J. C.
1991
5 p. 257-263
artikel
134 The Application of Prophylactic Antibodies for Rhinovirus Infections Privolizzi, Riccardo
2014
5 p. 173-177
artikel
135 The Design and Synthesis of Potent Inhibitors of Hepatitis C Virus NS3–4A Proteinase Attwood, MR
1999
5 p. 259-273
artikel
136 The Effect of Acyclovir on the Acute and Latent Murine Gammaherpesvirus-68 Infection of Mice Sunil-Chandra, N. P.
1994
5 p. 290-296
artikel
137 The Inhibitory Activity of Diazinyl-Substituted Thiourea Derivatives on Human Immunodeficiency Virus Type 1 Reverse Transcriptase Heinisch, G
1997
5 p. 443-446
artikel
138 Therapeutic Basis of Vidarabine on Adenovirus-Induced Haemorrhagic Cystitis Kurosaki, Kunikazu
2004
5 p. 281-285
artikel
139 The Structure-Activity Relationships of 2,4(1H,3H)-pyrimidinedione Derivatives as potent HIV type 1 and type 2 inhibitors Buckheit, Robert W
2007
5 p. 259-275
artikel
140 The Use of Antisera to the Human Herpesvirus 6 Major Capsid Protein to Determine the Effect of Antiviral Inhibitors on Virus Gene Expression Liu, M.-Y.
1990
5 p. 313-318
artikel
141 4′-Thio-5-Ethyl-2′-Deoxyuridine5′-Triphosphate (TEDUTP): Synthesis and Substrate Properties in DNA-Synthesizing Systems Alexandrova, L.A.
1996
5 p. 237-242
artikel
142 Tin Protoporphyrin IX Used in Control of Heme Metabolism in Humans Effectively Inhibits HIV-1 Infection Neurath, A. R.
1994
5 p. 322-330
artikel
143 Topical SMIP-7.7, a Toll–Like Receptor 7 Agonist, Protects against Genital Herpes Simplex Virus Type-2 Disease in the Guinea Pig Model of Genital Herpes Bernstein, David I
2014
5 p. 189-196
artikel
144 Topical Treatment of Cutaneous Vaccinia Virus Infections in Immunosuppressed Hairless Mice with Selected Antiviral Substances Smee, Donald F
2011
5 p. 201-208
artikel
145 Treatment of Mannan-Enhanced Influenza B Virus Infections in Mice with Oseltamivir, Ribavirin and Viramidine Smee, Donald F
2004
5 p. 261-268
artikel
146 Variability in the PR and RT Genes of HIV-1 Isolated from Recently Infected Subjects Turner, Dan
2004
5 p. 255-259
artikel
                             146 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland